ACADIA Pharmaceuticals
ACADIA Pharmaceuticals
Employees:
400
Market Cap:
$3.16 billion
Revenue:
$124.95 million
5 Year Trend:
91.0%
Net Income:
$-270.83 million
Stock:
ACAD

ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinsons disease psychosis. Wikipedia

ACADIA Pharmaceuticals
Are you from ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinsons disease psychosis. Wikipedia

Employees:
400
Market Cap:
$3.16 billion
Revenue:
$124.95 million
5 Year Trend:
91.0%
Net Income:
$-270.83 million
Stock:
ACAD

23 jobs at ACADIA Pharmaceuticals

Jobs in